FIELD: medicine, neurology, biochemistry. SUBSTANCE: invention proposes the use of glycoseaminoglycans extracted from the human placenta as an active component of an agent for treatment of patients with neurological diseases. The agent shows high therapeutic effectiveness, it does not induce toxic effect since exhibits homology with respect to human body tissues. Invention can be used in pharmacology for development of new medicinal preparations. EFFECT: enhanced effectiveness of agent. 10 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENT WITH SHINGLES | 1997 |
|
RU2140786C1 |
METHOD OF TREATMENT OF PATIENT WITH REFLEX SYNDROME AT OSTEOCHONDRITIS | 1996 |
|
RU2135186C1 |
OINTMENT FOR TREATMENT OF PATIENTS WITH SICKNESSES CAUSED BY HERPES VIRUS | 1997 |
|
RU2130304C1 |
METHOD OF PRODUCING MATERIAL WITH ANTIBACTERIAL PROPERTY | 1998 |
|
RU2157244C2 |
METHOD OF FORMATION OF HEPARINIZED SURFACE | 1998 |
|
RU2155593C2 |
METHOD OF ANTICOAGULANT SURFACE FORMING | 1998 |
|
RU2152217C1 |
METHOD OF FORMATION OF HEPARINIZED SURFACE | 1998 |
|
RU2137507C1 |
METHOD FOR PROPHYLAXIS OF REOCCLUSIONS IN CASE OF OPERATIONS CONDUCTED UPON THE MAIN VESSELS | 1999 |
|
RU2185171C2 |
METHOD OF PREVENTING ASEPTIC INFLAMMATION DURING OPERATIONS ON GREAT VESSELS | 1999 |
|
RU2180846C2 |
METHOD OF MODIFIED HYALURONIC ACID PREPARING | 2000 |
|
RU2191782C2 |
Authors
Dates
1999-07-27—Published
1996-02-13—Filed